Browsing Category
LIFE SCIENCES
Asylia Therapeutics Closes $14.5M – The Buttonwood Tree
Development-stage biotechnology company, Asylia Therapeutics has closed $14.5 million in financing. Founded in…
IPOs SPACs Life Sciences the Rise in Popularity
Despite the COVID-19 global pandemic, 2020 was an eventful year in the life sciences and technology sector.…
Vaccine Rollout: How Countries Compare
Ever since the arrival of the pandemic, there have been efforts towards creating a suitable vaccine. Since the…
Wesana Health Earns $4M in Convertible Note Financing
Emerging life sciences company, Wesana Health has closed its $4 million convertible note financing round.…
Challenges in Life Sciences: What 2020 Meant for This Industry
When we compare life sciences and healthcare to other industries, the strategy in the former is much more…
James Woody Explores New Horizons in Enosi Life Sciences
Enosi Life Sciences announced that it has appointed Dr. James Woody as its Executive Chairman. Having immense…
Life sciences and the state of its job market in the U.S.
The advent of coronavirus has threatened almost every job industry operating in the U.S. This has further…
The Word on the Covid-19 Vaccine: What We Know So Far
It would be an understatement to say that 2020 was a difficult year for everyone without a vaccine. Most of…
Decibel Therapeutics Secures $82 Million
Decibel Therapeutics Inc., a Boston-based organization dedicated to treating hearing and balance disorders, is…
CereVasc Raises $43.9 Million for eShunt System
Cerevasc is a Boston-based company that develops novel treatments for people who are suffering from…